2026

2025

• Shammas et al. Subst Use Addctn J. 2025 - Pharmacists' Experiences With Cases of Suspected Drug Misuse: A Cross-Sectional Study
• Kotoula et al. BMJ Open. 2025 - Efficacy of paracetamol added to WHO step III opioids in chronic pain control: study protocol for a randomised, double-blind, placebo-controlled, non-inferiority, multicentre study in Switzerland
• Miró et al. Addiction. 2025 - Changes in clinical features and severity in patients presenting to European emergency departments with acute cannabis toxicity over the 10-year period from 2013 to 2022
• Chaccour et al. eClinical mEDICINE. 2025 - Ivermectin to reduce malaria transmission– safety and efficacy results from the BOHEMIA cluster randomized trial in Mozambique
• Abderhalden et al. Int J Clin Pharm. 2025 - Implementing a clinical pharmacy intervention for older adult inpatients with chronic non-cancer pain: a feasibility study
• De Geest et al. Swiss Med Wkly. 2025 - Accelerating innovation: implementation science as a cornerstone of high-performance Swiss research infrastructures
• Meyer-Massetti et al. Drug Healthc Patient Saf. 2025 - Establishing Interprofessional Medication Reviews in Home Care Patients – A Feasibility Study
• Goetschi et al. J Pain Res. 2025 - Developing Quality Indicators for the Pharmacological Management of Chronic Non-Cancer Pain in Older Adult Inpatients: A RAND/UCLA Delphi Study
• Stoyanova et al. Swiss Med Wkly 2025 - PharmVisit: Reducing medication-related problems through an interprofessional ward round process in acute geriatric care – a quality improvement project
• Schönenberger et al. Swiss Med Wkly 2025 - Preventable medication-related readmissions involving older adults: a retrospective cohort analysis
• Lötscher et al. Nursing Reports 2025 - Medication Logistics in Professional Homecare Organisations: An Assessment of the Practical Implementation of Regulations and Recommendations
• Van der Velpen et al. Eur J Prev Cardiol 2025 - Intake of high-intensity statin after acute myocardial infarction assessed by direct drug concentration measurement: association with LDL-C response and coronary plaque modifications in the PACMAN-AMI trial
• Chaccour et al. N Engl J Med 2025 - Ivermectin to Control Malaria — A Cluster-Randomized Trial
• Christen et al. Tabacco Induced Diseases 2025 - Knowledge and perceptions of nicotine, smoking cessation and electronic nicotine delivery systems among physicians and pharmacists in a Swiss hospital group
• Möckli et al. Journal of Nursing Management 2025 - Work Environment and Work Context Factors Associated With Homecare Workers’ Intention to Leave: An Analysis of a National, Multicenter Cross-Sectional Study
• Miró et al. Am J Emerg Med. 2025 - Age and sex related differences in clinical manifestations and severity of acute cocaine toxicity presentations to European emergency departments
• Senguapta et al. Scientific reports 2025 - A next-generation system for smoke inhalation integrated with a breathing lung-on-chip to model human lung responses to cigarette exposure
• Vischer et al. Kidney and Blood Press Res 2025 - Monotherapy Blood Pressure Response and Control Rates in Treatment-Naïve Patients with Arterial Hypertension: A Randomized Comparison of Four Different Antihypertensive Drug Classes
• Meyer-Massetti et al. Nursing Reports 2025 - The doMESTIC RISK Tool: Prioritising Home-Care Patients for Clinical Pharmacy Services with the Help of a Delphi Study
• Schönenberger et al. JACCP 2025 - Development of a screening tool to flag older adults at a high risk of preventable medication‐related readmissions
• Martins et al. J Adv Nurs 2025 - Burnout and Back Pain and Their Associations With Homecare Workers' Psychosocial Work Environment—A National Multicenter Cross-Sectional Study
• Meyer-Massetti et al. BMC Health Services Reserach 2025 - Medication-related infrastructure and medication reviews in nursing homes—a rapid appraisal study
• Ouwerkerk et al. Clinical Toxicology 2025 - Differences in the clinical presentation of acute 3,4- methylenedioxymetamfetamine intoxication by co-intoxication and patient sex to European emergency departments
• Zellner et al. PLoS One 2025 - Emergency admission, previous delirium tremens and increased liver stiffness as risk factors for severe alcohol withdrawal – A prospective study
• Aegerter et al. J Pham Pharmacol Res 2025 - Patient Knowledge Regarding Paracetamol at An Internal Medicine Outpatient Clinic in Switzerland: A Cross-Sectional Study
• Hammann et al. The Lancet Infectious Diseases 2025 - Beyond mosquitoes and malaria—ivermectin in Africa
• van der Velpen et al. J Pharm Biomed Anal. 2025 - A validated single-step saliva and serum sample extraction LC-MS/MS method for the analysis of nicotine, cotinine and 3’-hydroxycotinine for clinical vaping studies

Review articles

• Goetschi et al. Journal of Evaluation in Clinical Practice 2025 - Quality Indicators for the Pharmacological Management of Chronic Non-Cancer Pain in Older Adult Patients: An Integrative Review
• Christen et al. Swiss Med Wkly 2025 - Caffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substances

Case reports

• Hermann et al. Swiss Med Preprints 2025 - Fluorouracil-induced neurotoxicity: risk factors, clinical impact, and management strategies

Other publications

• Abderhalden et al. pharmaJournal 11.2025 - Erweiterte Rolle von klinischen Pharmazeuten bei chronischen Schmerzen
• Zlateva et al. pharmaJournal 10.2025 - Lieferengpassmanagement: Aktuelle Praktiken und Optimierungsstrategien
• Lardi et al. pharmaJournal 10.2025 - Medizinischer Qualitätsindikator «Medikationsreview»
• Lardi et al. pharmaJournal 7.2025 - Medikationssicherheit erhöhen durch pharmazeutische Intervention
• Lötscher et al. Pflegerecht- Plfege in Politik, Wissenschaft und Ökonomie 2/2025 - Medikamentenlogistik bei der Spitex – regulatorische Bestimmungen und Empfehlungen
• Lötscher et al. Spitex Magazin I 02/2025 - Medikamentenlogistik in Spitex-Organisationen

2024

• Dahmke et al. Drugs - Real World Outcomes 2024 - Evaluation of Triple Whammy Prescriptions After the Implementation of a Drug Safety Algorithm
• Schönenberger et al. Res Social Adm Pharm. 2024 Feb 27 - Developing indicators for medication-related readmissions based on a Delphi consensus study
• Haschke et al. Br J Clin Pharmacol. 2024 - Food-derived compounds for CYP-phenotyping
• Gut et al. Swiss Med Wkly. 2024 - Use of metamizole and other non-opioid analgesics in Switzerland between 2014 and 2019: an observational study using a large health insurance claims database
• Anliker-Ort et al. J Clin Pharm. 2024 - Pharmacokinetics-Based Pediatric Dose Evaluation and Optimization Using Saliva – A Case Study
• Möckli et al. BMC Health Serv Res. 2024 - How external and agency characteristics are related to coordination in homecare - findings of the national multicenter, cross-sectional SPOTnat study
• Christen et al. Nicotine & Tobacco Research, 2024 - Pharmacokinetics and pharmacodynamics of inhaled nicotine salt and free-base using an e-cigarette: A randomized crossover study
• Drewe et al. Pharmaceutics 2024 - Machine Learning-Based Analysis Reveals Triterpene Saponins and Their Aglycones in Cimicifuga racemosa
  as Critical Mediators of AMPK Activation
• Stuby et al. Thromb Res. 2024 - Oral anticoagulant therapy in older adults
• Goetschi et al. Eur J Pain. 2024 - Prescribing pattern insights from a longitudinal study of older adult inpatients with polypharmacy and chronic non-cancer pain
• Goetschi et al. Int J Clin Pharm 2024 - Characterising pharmacists’ interventions in chronic non-cancer pain care: a scoping review
• Bekka et al. International Journal of Analytical Chemistry 2024 - Residents’ Knowledge regarding Recreational Drug Screening Immunoassays at a Swiss Hospital Group
• Bekka et al. Br J Clin Pharmacol. 2024 - Anticoagulation reversal (vitamin K, prothrombin complex concentrates, idarucizumab, andexanet-α, protamine)
• Waters et al. Clinical Toxicology 2024 - Clinical effects of cannabis compared to synthetic cannabinoid receptor agonists (SCRAs): a retrospective cohort study of presentations with acute toxicity to European hospitals between 2013 and 2020
• Pahud de Mortanges et al. COVID 2024 - Effect of SARS-CoV-2 Infection on Renal and Hepatic Function after NSAID and Paracetamol Therapy
• Hermann et al. J Antimicrob Chemother 2024 - Population pharmacokinetics of flucloxacillin as intermittent bolus infusion in patients with Staphylococcus aureus bloodstream infection
• Kamau et al. Int J Infect Dis. 2024 - Mosquitocidal efficacy and pharmacokinetics of single-dose ivermectin versus three-day dose regimen for malaria vector control in comparison with albendazole and no treatment: an open-label randomized controlled trial
• Bausch et al. Antibiotics 2024 - Target Attainment and Population Pharmacokinetics of Cefazolin in Patients with Invasive Staphylococcus aureus Infections: A Prospective Cohort Study
• Stritt et al. Trials 25 2024 - UROPOT: study protocol for a randomized, double-blind phase I/II trial for metabolism-based potentiation of antimicrobial prophylaxis in the urological tract
• Liakoni et al. Swiss Med Wkly. 2024 - E-cigarettes, synthetic nicotine, heated-tobacco and smokeless nicotine delivery products: the nicotine landscape beyond combustible cigarettes

Case reports

• Ziaka et al. Int J Immunopathol Pharmacol. 2024 - Probable drug-induced systemic reaction without blood eosinophilia and rash- utility of eosinophilic cationic protein for diagnosis

Other publications

• Meyer-Massetti. Pflegerecht – Pflege in Politik, Wissenschaft und Ökonomie 2|2024 - Medikationsmanagement in Spitex-Organisationen – eine pharmazeutische Perspektive

 

2023

• Buetler et al. Clin Toxicol (Phila). 2023 - Characteristics of emergency department presentations following ingestion of Taxus baccata (yew)
• Dixe et al. Int. J. Environ. Res. Public Health 2023 - Patterns of Medication Management and Associated Medical and Clinical Features among Home-Dwelling Older Adults: A Cross-Sectional Study in Central Portugal
• Wernli et al. Int J Clin Pharm. 2023 - Pharmacists’ clinical roles and activities in inpatient hospice and palliative care: a scoping review
• Möckli et al. Heliyon. 2023 - Clarifying the muddy concept of home healthcare coordination: A comprehensive theoretical framework
• Mulder et al. Pharmacy 2023 - Counselling for Chronic Insomnia in Swiss Pharmacies: A Survey Study Based on Case Vignettes
• Möckli et al. International Journal of Nursing Studies 2023 - Care coordination in homecare and its relationship with quality of care: A national multicenter cross-sectional study
• Kern et al. Malaria Journal 2023 Jun 24 - Pharmacokinetics of ivermectin metabolites and their activity against Anopheles stephensi mosquitoes
• Favez et al. International Journal of Clinical Pharmacy - Exploring medication safety structures and processes in nursing homes: a cross‑sectional study
• Liakoni et al. Swiss Medical Forum | 2023;23(38) - Medikamentöse Unterstützung beim Rauchstopp
• Noseda et al. Journal of Clinical Medicine 2023 - Determinants of Admission to Critical Care Following Acute Recreational Drug Toxicity: A Euro-DEN Plus Study
• Schönenberger et al. BMC Health Serv Res. 2023 - Risk factors for medication-related short-term readmissions in adults - a scoping review
• Pereira et al. BMJ Open. 2023 - Development of a patient-centred medication management model for polymedicated home-dwelling older adults after hospital discharge: results of a mixed methods study
• Vallersnes et al. Int J Emerg Med 16, 86 (2023) - Self-discharge during treatment for acute recreational drug toxicity: an observational study from emergency departments in seven European countries

Case reports

• Fuest et al. Swiss Medical Forum - Lokale Gewebeschädigung nach Wundspülung unter Druck mit Antiseptikum

Other publications

• Lardi et al. pharmaJournal 5 | 5.2023. Inadäquate Polypharmazie erkennen – und «behandeln»

• Banholzer et al. Swissmedic Vigilance-News | Edition 31 – November 2023. COVID-19-Impfstoffe: Wird die Einstufung «medizinisch wichtig» in den UAW-Meldungen korrekt angewendet, und gibt es Unterschiede zwischen den Meldungen von medizinischen Fachpersonen und von Patienten?

• Bekka et al. pharma-kritik 2023; 45(3). Interaktionen von Phytopharmaka

2022

• Duthaler et al. Clin Pharmacokinet 2022 - Liver Cirrhosis Affects the Pharmacokinetics of the Six Substrates of the Basel Phenotyping Cocktail Differently
• Varum et al. Int J Pharm. 2022 - Targeted colonic release formulations of mesalazine - A clinical pharmaco-scintigraphic proof-of-concept study in healthy subjects and patients with mildly active ulcerative colitis
• Schöning et al. J Transl Med. 2022 - Revalidating the prognostic COVID-19 severity assessment (COSA) score for variants of concern
• Heier et al. Eur J Emerg Med. 2022 - Clinical effect of ethanol co-use in patients with acute drug toxicity involving the use of central nervous system depressant recreational drugs
• Crulli et al. Clin Toxicol (Phila). 2022 - Novel psychoactive substances-related presentations to the emergency departments of the European drug emergencies network plus (Euro-DEN plus) over the six-year period 2014-2019
• Schöning et al. Pharmaceutics. 2022 - Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients
• Schöning et al. Front Pharmacol. 2022 - Effectiveness of Antiviral Therapy in Highly-Transmissable Variants of SARS-CoV-2: A Modeling and Simulation Study
• Wernli et al. J Pain Symptom Manage. 2022 - Subcutaneous Drugs and Off-label Use in Hospice and Palliative Care: A Scoping Review
• Schönenberger et al. Eur J Hosp Pharm. 2022 - Development of a quality assessment tool for pharmacy and therapeutics committees and subsequent pilot testing
• Wernli et al. Am J Hosp Palliat Care. 2022 - Prescription Trends in Hospice Care: A Longitudinal Retrospective and Descriptive Medication Analysis
• Pereira et al. BMJ Open. 2022 - Unplanned nursing home admission among discharged polymedicated older inpatients: a single-centre, registry-based study in Switzerland
• Gnägi et al. J Adv Nurs. 2022 - Development of a medication literacy assessment instrument (MELIA) for older people receiving home care
• Zerah et al. Age Ageing. 2022 - Performance of a trigger tool for detecting drug-related hospital admissions in older people: analysis from the OPERAM trial
• Gerbier et al. Int J Environ Res Public Health. 2022 - Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study
• Schmid et al. Clin Toxicol (Phila). 2022 - Differences in clinical features associated with cannabis intoxication in presentations to European emergency departments according to patient age and sex

Review articles

• Benowitz et al. Addiction. 2022 - Tobacco use disorder and cardiovascular health

Case reports

• Stutz et al. Swiss Med Forum. 2022 - Rezidivierender Priapismus – unerwünschte Wirkung einer Therapie mit Neuroleptika
• Buetler et al. Front Med (Lausanne) 2022 - Immune-Mediated Thrombotic Thrombocytopenic Purpura Following mRNA-Based COVID-19 Vaccine BNT162b2: Case Report and Mini-Review of the Literature
• Banholzer et al. Vigilance-News, Swissmedic, 2022 - Erfolgreiche Re-Exposition mit COVID-19-mRNA-Impfung in reduzierter Dosierung bei Patient mit klinischem Verdacht auf Peri-/Myokarditis nach erster COVID-19-Impfung

Other publications

• Schröder et al. pharmaJournal, 2022 - Das neue Vollstudium in Pharmazie an der Universität Bern
• Eschbach et al. pharmaJournal, 2022. - Pharmazeutisches Stationsmanagement – Aktueller Stand in Schweizer Spitälern und ein Ausblick in die Zukunft
• Meyer-Massetti et al. pharmaJournal, 2022 - Pharmazeutisches Stationsmanagement – Neue Aufgaben für die Pharma-Assistentinnen und –Assistenten
• Wernli et al. Sichere und rationale Medikation im Hospiz-Setting – eine neue Rolle für Apotheker:innen?

2021

• Preisig D et al. Eur J Pharm Biopharm. 2021 -  Colonic delivery of metronidazole-loaded capsules for local treatment of bacterial infections: A clinical pharmacoscintigraphy study.
• Bachmann F et al. Clin Pharmacol Ther. 2021 - Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2. 
• Drewe J et al. Molecules 2021 - Modelling structure activity relationship of AMPK activation.
• Wertli M et al. BMJ Open 2021 - Efficacy of metamizole versus ibuprofen and a short educational intervention versus standard care in acute and subacute low back pain: a study protocol of a randomised, multicentre, factorial trial (EMISI trial)
• Benowitz NL et Liakoni E. Addiction 2021 - Tobacco Use Disorder and Cardiovascular Health
• Kummer M et al. Int J Environ Res Public Health 2021 - Characteristics of Presentations to the Emergency Department Following Attempt Suicide with Drugs
• Blaser LS et al. Front Pharmacol 2021 - Comparative Effects of Metamizole (Dipyrone) and Naproxen on Renal Function and Prostacyclin Synthesis in Salt-Depleted Healthy Subjects - A Randomized Controlled Parallel Group Study
• Benowitz NL et al. J Clin Pharmacol 2021 - Clincal Pharmacology of Electronic Nicotine Delivery Systems (ENDS): Implications for Benefits and Risks in the Promotion of the Combusted Tobacco Endgame
• Miro O et al. Clin Toxicol 2021 - Variation of drugs involved in acute drug toxicity presentations based on age and sex: an epidemiological approach based on European emergency departements
• Müller AM, et al. J Gen Intern Med 2021 - The Risk of Muscular Events Among New Users of Hydrophilic and Lipophilic Statins: an Observational Cohort Study
• Liakoni E, et al. Pharmacogenet Genomics 2021 - Effect of race and glucuronidation rates on the relationship between nicotine metabolite ration and nicotine clearance
• Kern C, et al. Front Pharmacol 2021 - Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing
• Duthaler U, et al. Plos Pathogens 2021 - The pharmacokinetics and drug-drug interactions of ivermectin in Aedes aegypti mosquitoes
• Nicolas P, et al. Parasites Vectors 2021 - Potential metabolic resistance mechanisms to ivermectin in Anopheles gambiae: a synergist bioassay study
• Vischer AS, et al. Cells 2021 - Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive Patients
• Banholzer S, et al. SMW 2021 - Retrospective analysis of adverse drug reactions leading to short-term emergency hospital readmission
• Schöning V, et al. J Transl Med 19, 56 (2021) - Development and validation of a prognostic COVID-19 severity assessment (COSA) score and machine learning models for patient triage at a tertiary hospital.
• Zerah L, et al. BMC Geriatr 2021 - Prevalence of drug-drug interactions in older people before and after hospital admission: analysis from the OPERAM trial
• Zerah L, et al. Age Ageing. 2021 - Performance of a trigger tool for detecting drug-related hospital admissions in older people: analysis from the OPERAM trial
• Glinz D, et al. J Hypertens. 2021 - Hemodynamic profiles in treatment-naive arterial hypertension and their clinical implication for treatment choice: an exploratory post hoc analysis
• Chaccour C, et al. EClinicalMedicine. 2021 - The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial
• Helma C, et al. Front Pharmacol. 2021 - A Comparison of Nine Machine Learning Mutagenicity Models and Their Application for Predicting Pyrrolizidine Alkaloids
• Diedrich D, et al. Z Gerontol Geriatr. 2021 - Medikationsmanagement in der häuslichen Pflege – der Medikationsprozess aus der Perspektive von Klient:innen und ihren Angehörigen
• Romann V, et al. Swiss Med Wkly. 2021 - Presentations with reported methamphetamine use to an urban emergency department in Switzerland

2020

• Chaccour, et. al. Sci Rep 2020 - Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats
• Grafinger, et. al. Br J Clin Pharmacol 2020 - Clinical value of analytical testing in patients presenting with new psychoactive substances intoxication
• Schmid, et. al. Drug Alcohol Depend 2020 - Emergency department presentations related to acute toxicity following recreational use of cannabis products in Switzerland
• St Helen, et. al. Cancer Prev Res (Phila) 2020 - Comparison of Systemic Exposure to Toxic and/or Carcinogenic Volatile Organic Compounds (VOC) during Vaping, Smoking, and Abstention
• Liakoni, et. al. Nicotine Tob Res 2020 - Effects of Nicotine Metabolic Rate on Cigarette Reinforcement
• Suenderhauf, et. al. Br J Clin Pharmacol 2020 - Pharmacokinetics and phenotyping properties of the Basel phenotyping cocktail combination capsule in healthy male adults
• Boschung-Pasquier, et. al. Clin Microbiol Infect 2020 - Cefepime neurotoxicity: thresholds and risk factors. A retrospective cohort study
• Bachmann, et al. Clin Pharmacol Ther 2020 - Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2
• Stojkov, et al. Blood Adv 2020 - Guideline-based indicators for adult patients with myelodysplastic syndromes
• Scholz, et al. Br J Pharmacol 2020 - Effects of Hypericum perforatum (St John's wort) on the pharmacokinetics and pharmacodynamics of rivaroxaban in humans
• Cismaru, et al. Genes 2020 - Genome-Wide Association Study of Metamizole-Induced Agranulocytosis in European Populations
• Cismaru, et al. Front Gen 2020 - High-Throughput Sequencing to Investigate Associations Between HLA Genes and Metamizole-Induced Agranulocytosis
• Noseda, et al. Clin Toxicol 2020 - MDMA-related presentations to the emergency departments of the European Drug Emergencies Network plus (Euro-DEN Plus) over the four-year period 2014–2017
• Chaccour, et al. Am J Trop Med Hyg 2020 - Ivermectin and Novel Coronavirus Disease (COVID-19): Keeping Rigor in Times of Urgency
• Bachmann et al., Bioanalysis 2020 - Development and validation of an LC-MS/MS method for the bioanalysis of the major metamizole metabolites in human plasma
• Liakoni, et al. Swiss Medical Weekly 2019 - Characteristics  of emergency  department presentations  requiring  consultation  of the national  Poisons  Information  Centre
• Piotrowska, et al. Emerg Med Intern 2019 - Presentations Related to Acute Paracetamol Intoxication in an Urban Emergency Department in Switzerland
• Duthaler, et al. J Antimicrob Chemother 2019 - The effect of food on the pharmacokinetics of oral ivermectin

2019

• Schmid, et al. Drug Alc Dep 2019 - Emergency department presentations related to acute toxicity following recreational use of cannabis products in Switzerland
• Liakoni, et al. Nicotine and Tobacco Research 2019 - Effects of Nicotine Metabolic Rate on Cigarette Reinforcement
• Ziesenitz, et al. Eur J Clin Pharm 2019 - Dose evaluation of intravenous metamizole (dipyrone) in infants and children: a prospective population pharmacokinetic study
• Rudin, et al. Eur J Intern Med 2019 - Metamizole-associated neutropenia: Comparison of patients with neutropenia and metamizole-tolerant patients
• Benowitz, et al. Drug Alcohol Depend 2019 - Quantitative biochemical screening for marijuana use and concordance with tobacco use in urban adolescents
• Grafinger, et al. Br J Clin Pharm 2019 - Clinical value of analytical testing in patients presenting with new psychoactive substances intoxication
• Liakoni, et al. Drug Alcohol Depend 2019 - Relationship between skin melanin index and nicotine pharmacokinetics in African American smokers
• St Helen, et al. Cancer Prev Res 2019 - Comparison of Systemic Exposure to Toxic and/or Carcinogenic Volatile Organic Compounds (VOC) during Vaping, Smoking, and Abstention
• Boschung-Pasquier, et al. Clin Micro-biol Infect 2019 - Cefepime neurotoxicity: thresholds and risk factors. A retrospective cohort study
• Scholz, et al. SMW 2019 - Emergency department presentations related to abuse of prescription and over-the-counter drugs in Switzerland: time trends, sex and age distributions
• Hoemme, et al. Cancer Chemother Pharmacol 2019 - Prognostic impact of polypharmacy and drug interactions in patients with advanced cancer
• Rudin, et al. Biochem Pharmacol 2019 - Non-immunological toxicological mechanisms of metamizole-associated neutropenia in HL60 cells